Jim Cramer has been negative on Elan Corporation (ELN) through 2005 and 2006 but when recently queried in the June 18, 2007 lightning round, he reported "I've been too negative on Elan (ELN)"..."At $21 bucks, it's got that great relationship with Biogen Idec (BIIB)"..."The safety of Tysabri is no longer in question as far as I'm concerned. That stock is going higher!" The stock has pulled back recently but Cramer has mentioned healthcare and drugs as industries that will benefit from the financials' downturn.
Subscribe to:
stockTagger (Feedburner)

Subscribe by Email




0 comments:
Post a Comment